Group effects, uncertainty and shrinkage
Parametric Empirical Bayes
Parametric Empirical Bayes lets us ask whether model parameters differ across people, groups or symptoms, while respecting the uncertainty in each person's parameter estimates.
1. The problem
In Dynamic Causal Modelling, each participant has estimated parameters: for example synaptic gain, receptor time constants, connection strengths or delays. But these estimates are uncertain. PEB gives us a principled way to model how subject-level parameters depend on group-level predictors.
$\theta_i = X_i\beta + \varepsilon_i$
Here, $\theta_i$ is a subject-level parameter, $X_i$ contains group or symptom predictors, and $\beta$ contains the group-level effects.
2. Interactive PEB intuition
Each point is a subject-level parameter estimate. The vertical bars show uncertainty. The coloured dots show the shrinkage estimate: uncertain subjects are pulled more strongly toward the empirical group model.
3. Shrinkage is a feature, not a bug
Empirical Bayes uses the group-level model to provide empirical priors on subject-level parameters. Noisy estimates are not trusted blindly. Instead, they are partially pulled toward the group-informed expectation.
$\theta_i^{\text{PEB}} = w_i\theta_i^{\text{subject}} + (1-w_i)\theta_i^{\text{group}}$
The weight $w_i$ is larger when the subject-level estimate is precise and smaller when it is uncertain.
Subject level
Estimate each person's model parameters and uncertainty.
Group level
Explain parameters using predictors such as group, drug or symptoms.
Empirical priors
Use group structure to regularise individual estimates.
Posterior probability
Quantify confidence that an effect is positive or negative.
4. PEB as a hierarchy
PEB is easiest to understand as a hierarchy: data inform subject-level parameters, subject-level parameters inform group-level effects, and the group-level model feeds back as empirical priors.
EEG, MEG, spectra
with uncertainty
β parameters
Why this matters for our lab
PEB is central when we want to connect mechanistic model parameters to clinical or experimental variables. For example, we might ask whether NMDA gain differs between groups, whether GABA time constants predict symptoms, or whether a drug changes synaptic parameters after administration. PEB lets us make these inferences while propagating uncertainty from the first-level DCMs.